Obesity pipeline
Drugs
Every obesity program in this file, grouped by class. Open a drug for its studies and the sources behind each figure.
ClassNone selected
MechanismNone selected
Approved only.
Clear filters5 of 94 programs shown
GLP-1 RA 2 drugs
- LiraglutideSaxendaNovo NordiskApprovedsubcutaneous30 studiesGLP-1 RA
- SemaglutideWegovyNovo NordiskApprovedsubcutaneous and oral37 studiesGLP-1 RA
GLP-1/GIP 1 drug
- TirzepatideZepboundEli LillyApprovedsubcutaneous41 studiesGLP-1/GIP
Oral small molecule 1 drug
- OrforglipronFoundayoEli LillyApprovedoral23 studiesOral small molecule
Lipase inhibitor 1 drug
- OrlistatXenicalEmpros Pharma ABApprovedoral12 studiesLipase inhibitor